KÜÇÜKŞAHİN, O. Et Al. 2022. Comparison of anakinra and tocilizumab in management of severe COVID-19: a retrospective cohort study. Turkish Journal of Medical Sciences , vol.52, no.5 , 1486-1494.

KÜÇÜKŞAHİN, O., Erden, A., Karakaş, Ö., Güven, S. C., Armağan, B., Şahiner, E. S., ... İnan, O.(2022). Comparison of anakinra and tocilizumab in management of severe COVID-19: a retrospective cohort study. Turkish Journal of Medical Sciences , vol.52, no.5, 1486-1494.

KÜÇÜKŞAHİN, ORHAN Et Al. "Comparison of anakinra and tocilizumab in management of severe COVID-19: a retrospective cohort study," Turkish Journal of Medical Sciences , vol.52, no.5, 1486-1494, 2022

KÜÇÜKŞAHİN, ORHAN Et Al. "Comparison of anakinra and tocilizumab in management of severe COVID-19: a retrospective cohort study." Turkish Journal of Medical Sciences , vol.52, no.5, pp.1486-1494, 2022

KÜÇÜKŞAHİN, O. Et Al. (2022) . "Comparison of anakinra and tocilizumab in management of severe COVID-19: a retrospective cohort study." Turkish Journal of Medical Sciences , vol.52, no.5, pp.1486-1494.

@article{article, author={ORHAN KÜÇÜKŞAHİN Et Al. }, title={Comparison of anakinra and tocilizumab in management of severe COVID-19: a retrospective cohort study}, journal={Turkish Journal of Medical Sciences}, year=2022, pages={1486-1494} }